Physician profile
Julian E Mcintyre
NPI 1366464216
$1,441.95
in general payments reported to CMS, 2019-2025
24 companies · $451 in 2025
The $451 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $12.97 · 2021: $115 · 2022: $214 · 2023: $157 · 2024: $372 · 2025: $451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $980.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $980.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $309.39 | 2024-2025 | Myfembree, Gemtesa |
| Aspira Women'S Health INC | $103.74 | 2022 | |
| Medical Device Business Services, INC. | $102.99 | 2021 | |
| Becton, Dickinson and Company | $99.25 | 2019-2025 | |
| Abbvie INC. | $84.89 | 2022-2024 | |
| Ethicon US, LLC | $75.38 | 2019-2025 | Enseal, Harmonic, Surgiflo Hemostatic Matrix |
| Viiv Healthcare Company | $74.34 | 2024 | |
| Organon LLC | $67.57 | 2022-2024 | Nexplanon |
| Hologic Sales and Service, LLC | $58.78 | 2023-2025 | Acessa Provu System, Sonata Sonography-Guided Transcervical Fibroid Ablation System, Aptima |
| Channel Medsystems, INC. | $57.79 | 2024 | |
| Shield Therapeutics INC | $53.39 | 2023-2025 | Accrufer |
| Sage Therapeutics, LLC | $50.37 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $49.41 | 2019-2024 | Veozah |
| Myriad Women'S Health, INC. | $48.20 | 2023 | Myrisk |
| Minerva Surgical, INC | $37.84 | 2023-2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $26.46 | 2025 | Quikclot |
| Avion Pharmaceuticals | $24.51 | 2020-2021 | |
| Bard Access Systems, INC. | $21.15 | 2019 | |
| Mimedx Group, INC. | $19.70 | 2024 | |
| Scynexis, INC. | $16.90 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.38 | 2022 | |
| Urgo Medical North America, LLC | $15.71 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Mylan Pharmaceuticals INC. | $14.39 | 2022 | |
| Amag Pharmaceuticals, INC. | $13.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julian Mcintyre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.